Axios Senolyics

Service Provisions

AXIOS Senolytics is an R&D oriented specialty pharmaceutical company dedicated to the development and commercialization of senolytic compounds, dietary supplements and drugs against aging, age-related degenerative diseases and cancer.

AXIOS Senolytics develops and operates an existing portfolio of senolytic drug candidates (trademarks, patents, industrial property rights) and leverages its research through partnership agreements with major pharmaceutical companies, both in the form of R&D contracts and licensing agreements per therapeutic application.

AXIOS Senolytics also offers its customers and partners a wide range of consulting and expertise services, from scientific and regulatory support for R&D projects to the development of specific products and formulas.

For more information about our services, please contact our sales department at contact@axios-senolytics.com or by telephone on +33 (0)9.81.75.70.07.

 

 

Services and benefits proposed

Project definition

Project definition

Development of formulas

Regulatory review of ingredients

  • Regulatory status of ingredients in Europe (specific substances or extracts)
  • Recommended doses
  • Restrictions on use
  • Recommendations for substances to be monitored
  • Parts of plants that can be used
  • Technical characteristics of ingredients
  • Impact on formulation

Sourcing of ingredients & quality constraints

  • Identification of potential suppliers
  • Compliance with European regulations
  • Analysis of quality documents submitted
  • Economic cost

Reformulation

  • Depending on the regulatory status of each ingredient and the doses to be incorporated, reformulation can be considered.

Regulatory filings – Tele-procedures

  • Labelling
  • Regulatory declarations

Trademark registration

Production

  • Identification of potential service providers
  • Request for quotation
  • Analysis of proposals submitted
  • Production start-up

Dedicated clinical trials

  • Regulatory implementation of clinical trials
  • Management and follow-up of clinical trials

Scientific publications

Industrial property & patenting